Literature DB >> 12453078

Risk factors for cryptogenic ischaemic stroke.

V Karttunen1, G Alfthan, L Hiltunen, V Rasi, K Kervinen, Y A Kesäniemi, M Hillbom.   

Abstract

This case-control study was designed to identify risk factors for cryptogenic brain infarction. We assessed the frequency of prothrombotic states, homocysteine, lipoprotein (a) [Lp(a)] and other lipids and the apolipoprotein E phenotype together with conventional risk factors in 46 patients (19 women and 27 men) with cryptogenic brain infarction aged from 15 to 60 years and in 104 community-based controls. Multivariate odds ratios (ORs) for risk factors and 95% CIs were calculated by logistic regression. Hypertension (OR 4.5; 95% CI, 1.5-13.2; P = 0.006), current smoking (OR 2.9; 95% CI, 1.2-6.8; P = 0.012), low HDL cholesterol (HDL-C) (OR 5.4; 95% CI, 1.1-25.5; P = 0.035) and high clotting factor VIII activity (OR 3.6; 95% CI, 1.1-12.2; P = 0.041) were variables associated with cryptogenic brain infarction. These risk factors were not equally frequent in women and men. Low HDL-C and high factor VIII activity in the women, and hypertension, current smoking and a low level of plasma folate in the men were risk factors for cryptogenic stroke. Several of the observed risk factors for cryptogenic brain infarction were lifestyle-associated, which emphasizes the role of health education in addition to pharmacological treatment in the prevention of stroke.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453078     DOI: 10.1046/j.1468-1331.2002.00464.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  10 in total

Review 1.  Factoring in Factor VIII With Acute Ischemic Stroke.

Authors:  James E Siegler; Alyana Samai; Karen C Albright; Amelia K Boehme; Sheryl Martin-Schild
Journal:  Clin Appl Thromb Hemost       Date:  2015-02-10       Impact factor: 2.389

2.  Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.

Authors:  Colum F Amory; Steven R Levine; Robin L Brey; Mulugeta Gebregziabher; Stanley Tuhrim; Barbara C Tilley; Ann-Catherin C Simpson; Ralph L Sacco; Jay P Mohr
Journal:  Cerebrovasc Dis       Date:  2015-10-29       Impact factor: 2.762

Review 3.  Association between Apolipoprotein ε4 Gene Polymorphism and Risk of Ischemic Stroke: A Meta-Analysis.

Authors:  Amit Kumar; Pradeep Kumar; Manya Prasad; Shubham Misra; Awadh Kishor Pandit; Kamalesh Chakravarty
Journal:  Ann Neurosci       Date:  2016-07-07

4.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

5.  Factor V Leiden does not have a role in cryptogenic ischemic stroke among Iranian young adults.

Authors:  Ehsan Kheradmand; Meraj Pourhossein; Gilda Amini; Mohammad Saadatnia
Journal:  Adv Biomed Res       Date:  2014-02-28

6.  Increased visceral adipose tissue as a potential risk factor in patients with embolic stroke of undetermined source (ESUS).

Authors:  Antti T Muuronen; Mikko Taina; Marja Hedman; Jarkko Marttila; Johanna Kuusisto; Juha Onatsu; Ritva Vanninen; Pekka Jäkälä; Petri Sipola; Pirjo Mustonen
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

Review 7.  Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice.

Authors:  Amre Nouh; Mohammed Hussain; Tapan Mehta; Shadi Yaghi
Journal:  Front Neurol       Date:  2016-03-21       Impact factor: 4.003

8.  Apolipoprotein E ε4 Polymorphism as a Risk Factor for Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Su-Ya Qiao; Ke Shang; Yun-Hui Chu; Hai-Han Yu; Xin Chen; Chuan Qin; Deng-Ji Pan; Dai-Shi Tian
Journal:  Dis Markers       Date:  2022-02-03       Impact factor: 3.434

9.  Lipoprotein (a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis.

Authors:  Pradeep Kumar; Priyanka Swarnkar; Shubham Misra; Manabesh Nath
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

10.  Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.

Authors:  Linxin Li; Gabriel S Yiin; Olivia C Geraghty; Ursula G Schulz; Wilhelm Kuker; Ziyah Mehta; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2015-07-27       Impact factor: 59.935

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.